Moleculin Biotech Inc.
MBRX | NASDAQ
$0.52
-$0.25 (-32.74%)
At close: Sep 21, 2026, 4:00 PM ET
$0.53
+$0.01 (+1.92%)
Pre-market:
Sep 22, 2026, 8:30 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.12 | -0.22 | -0.85 | -1.04 | -3.15 | -2.71 |
PEG Ratio | 0 | 0 | 0.86 | -0.01 | 0.05 | 0.29 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.26 | 0.98 | 0.98 | 0.58 | 0.63 | 2.63 |
P/FCF Ratio | -0.17 | -0.25 | -1.05 | -1.09 | -2.64 | -2.59 |
P/OCF Ratio | -0.17 | -0.25 | -1.06 | -1.10 | -2.64 | -2.65 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.08 | 0.02 | 0.01 | 0 | 0.02 |
Quick Ratio | 1.41 | 0.97 | 3.86 | 9.46 | 20.02 | 5.89 |
Current Ratio | 1.41 | 0.97 | 3.86 | 9.46 | 20.02 | 5.89 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -223.64% | -363.99% | -114.18% | -55.61% | -20.12% | -97.01% |
Return on Assets | -151.68% | -128.58% | -77.89% | -50.55% | -18.90% | -59.52% |
Return on Invested Capital | -162.91% | -227.97% | -94.06% | -58.12% | -28.51% | -74.90% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MBRX